Human Cytomegalovirus Resistance to Antiviral Drugs
Open Access
- 1 March 2005
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (3), 873-883
- https://doi.org/10.1128/aac.49.3.873-883.2005
Abstract
No abstract availableThis publication has 117 references indexed in Scilit:
- Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune responseJournal of Antimicrobial Chemotherapy, 2004
- Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient1Transplantation, 2003
- Susceptibilities of Human Cytomegalovirus Clinical Isolates to BAY38-4766, BAY43-9695, and GanciclovirAntimicrobial Agents and Chemotherapy, 2001
- Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein*Journal of Medical Virology, 2001
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Cytomegalovirus UL97 and Glycoprotein B (gB) Sequences in Tissues from Immunocompromised Patients with Ganciclovir-resistant Virus InfectionScandinavian Journal of Infectious Diseases, 1999
- Herpes Simplex Virus Type 1 DNA Polymerase: MUTATIONAL ANALYSIS OF THE 3′-5′-EXONUCLEASE DOMAINPublished by Elsevier BV ,1996
- FoscarnetDrugs, 1991
- Screening with a shell vial assay for antiviral activity against cytomegalovirusDiagnostic Microbiology and Infectious Disease, 1989
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989